Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last CNY35.46 CNY
Change Today -0.43 / -1.20%
Volume 6.9M
300238 On Other Exchanges
As of 3:00 AM 04/30/15 All times are local (Market data is delayed by at least 15 minutes).

grandhope biotech co ltd-a (300238) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/13/15 - CNY41.96
52 Week Low
05/19/14 - CNY18.82
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for GRANDHOPE BIOTECH CO LTD-A (300238)

Related News

No related news articles were found.

grandhope biotech co ltd-a (300238) Related Businessweek News

No Related Businessweek News Found

grandhope biotech co ltd-a (300238) Details

Grandhope Biotech Co., Ltd., a bio-tech company, develops, manufactures, and markets regenerative medical devices for the treatment of damaged tissue and organs in China. The company offers GrandNeuro membrane, an artificial dura patch for dura repairing; and NormalGEN, a type of biological dura repair patch manufactured from animal tissue used for the closure of dura mater during neurosurgery. It also provides ThormalGEN, a biological surgical patch manufactured from animal tissue for surgical repairs; and DermalGEN, a wound dressing product manufactured from animal tissue for use on burns, scalds, and wounds due to skin loss or trauma. In addition, the company is involved in the research and development of various products in the areas of menbranes, conduits, bones and ligament, and collagens. Grandhope Biotech Co., Ltd. was founded in 1999 and is headquartered in Guangzhou, China.

Founded in 1999

grandhope biotech co ltd-a (300238) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

grandhope biotech co ltd-a (300238) Key Developments

Guanhao Biotech Co., Ltd. to Report Q1, 2015 Results on Apr 24, 2015

Guanhao Biotech Co., Ltd. announced that they will report Q1, 2015 results on Apr 24, 2015

Grandhope Biotech Co., Ltd Approves Amendments to the Articles of Association; Approves Dividend for the Year 2014

Grandhope Biotech Co. Ltd. at the annual general meeting of 2014 held on March 19, 2015, approved amendments to the articles of association of the company. The company also approved a cash dividend of CNY 1.00000000 per 10 shares (tax included) for the year 2014, at its AGM held on March 19, 2015.

Grandhope Biotech Co., Ltd to Report Fiscal Year 2014 Results on Mar 03, 2015

Grandhope Biotech Co., Ltd announced that they will report fiscal year 2014 results on Mar 03, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300238:CH CNY35.46 CNY -0.43

300238 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 300238.
View Industry Companies

Industry Analysis


Industry Average

Valuation 300238 Industry Range
Price/Earnings 100.0x
Price/Sales 23.8x
Price/Book 8.4x
Price/Cash Flow 172.6x
TEV/Sales 44.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GRANDHOPE BIOTECH CO LTD-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at